SHOX2 and non-small cell lung carcinoma: A meta-analysis showed that SHOX2 methylation had higher sensitivity (70%) and specificity (96%) than carcinoembryonic antigen and cytokeratin 19 fragment antigen 21–1 in MPE associated with non-small cell lung cancer [19].